30 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.
Korea University
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
Academy Of Sciences Of The Czech Republic
Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy.
Mcmaster University
Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
Academy Of Sciences Of The Czech Republic
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo.
Johns Hopkins School Of Medicine
Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.
Washington State University
DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting.
Purdue University
Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
Academy Of Sciences Of The Czech Republic
d-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.
Johns Hopkins University
Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
Kyoto University
Radiofluorinated derivatives of 2-(phosphonomethyl)pentanedioic acid as inhibitors of prostate specific membrane antigen (PSMA) for the imaging of prostate cancer.
Bayer Healthcare
Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.
Eisai
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.
Washington State University
Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.
University Of Notre Dame
Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.
Academy Of Sciences Of The Czech Republic
Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen.
Washington State University
The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase II.
Eisai Research Institute
A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.
Washington State University
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.
Institutions
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.
Molecular Insight Pharmaceuticals
Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting.
Justus-Liebig-Universitat Giessen
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.
Institutions
The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.
San Francisco State University
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.
Guilford Pharmaceuticals
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
Guilford Pharmaceuticals
Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen.
University Of Oxford
2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics.
University Of Illinois At Chicago
Synthesis of novel multivalent fluorescent inhibitors with high affinity to prostate cancer and their biological evaluation.
Yonsei University College Of Medicine